Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial

Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non- Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial

Objective:To assess the efficacy and safety of 5α-R inhibitor dutasteride added to standard Bacillus Calmette-Guérin (BCG) immunotherapy for preventing recurrence and progression in intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC).Materials and Methods:Patients received BCG imm...

Full description

Bibliographic Details
Main Authors: Müslim Doğan Değer, Hüseyin Alperen Yıldız, Canet İncir, Selçuk Özer, Alper Ege Sarıkaya, Gül Ergör, Yeşim Tunçok, Volkan Şen, Ozan Bozkurt, Ahmet Adil Esen
Format: Article
Language:English
Published: Galenos Yayinevi 2023-03-01
Series:Journal of Urological Surgery
Subjects:
bladder cancer
dutasteride
recurrence
Online Access: http://jurolsurgery.org/archives/archive-detail/article-preview/efficacy-and-safety-of-a-5-alpha-reductase-nhibito/58883

Similar Items

Similar Items